Vitiligo: Generalized well circumscribed patches of leukoderma that are generally distributed over symmetric body locations and is due to autoimmune destruction of melanocytes.
Filter registries Inpat., Oupat., Death
Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule None
L12_VITILIGO
Extra metadata
List of similar endpoints to
Vitiligo
based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
None
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 156 | 88 | 68 |
| Unadjusted prevalence (%) | 0.06 | 0.06 | 0.06 |
| Mean age at first event (years) | 43.35 | 42.91 | 43.93 |
| Follow-up | Absolute risk | HR [95% CI] | p | N |
|---|---|---|---|---|
| 1998–2019 | - | - | - | - |
| 15 years | - | - | - | - |
| 5 years | - | - | - | - |
| 1 year | - | - | - | - |
Index endpoint: L12_VITILIGO – Vitiligo
GWS hits: 0
before Vitiligo
after Vitiligo
Loading survival analyses plot
Loading survival analyses table